Zealand Pharma A/S (CPH:ZEAL)

Zealand Pharma Revenue

Zealand Pharma had revenue of 4.49B DKK in the quarter ending June 30, 2026, a decrease of -50.58%. This brings the company's total for the last twelve months to 4.64B, down -49.03% year-over-year. In the year 2025, Zealand Pharma had annual revenue of 9.21B with 14,598.86% growth. That makes Zealand Pharma the 9,424th largest company in the world by revenue and 42nd in Denmark.

• Revenue (ttm): 4.64B
• Revenue Growth: -49.03%
• P/S Ratio: 3.43
• Revenue / Employee: 8.03M
• Employees: 578
• Market Cap: 15.95B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Switzerland 9.18B 99.6%
• Denmark 34.90M 0.4%

Fiscal year ended Dec 31, 2025 See the full Zealand Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.21B	9.15B	14,598.86%
Dec 31, 2024	62.69M	-280.10M	-81.71%
Dec 31, 2023	342.79M	238.80M	229.65%
Dec 31, 2022	103.99M	-4.56M	-4.20%
Dec 31, 2021	108.55M	-83.46M	-43.47%
Dec 31, 2020	192.00M	150.67M	364.52%
Dec 31, 2019	41.33M	3.36M	8.84%
Dec 31, 2018	37.98M	-98.35M	-72.14%
Dec 31, 2017	136.32M	-94.54M	-40.95%
Dec 31, 2016	230.86M	43.19M	23.01%
Dec 31, 2015	187.68M	33.90M	22.05%
Dec 31, 2014	153.77M	147.20M	2,239.11%
Dec 31, 2013	6.57M	-216.99M	-97.06%
Dec 31, 2012	223.57M	81.28M	57.13%
Dec 31, 2011	142.28M	54.93M	62.88%
Dec 31, 2010	87.36M	62.04M	245.03%
Dec 31, 2009	25.32M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error